Published Date: 17 Feb 2023
BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...
Read Full NewsFrank Sciurba, MD, reports tozorakimab improved E-RS:COPD scores vs placebo at week 52 in OBERON and TITANIA, including breathlessness and chest symptoms.
Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD
Joanna Wardlaw, MD, Professor of Applied Neuroimaging at the University of Edinburgh, discusses the evolving understanding of cerebral small vessel disease, emerging therapeutic approaches, and the makings behind a successful trial.
Paul Melmeyer, MPP, Executive Vice President of Public Policy and Advocacy at the Muscular Dystrophy Association, discusses the Neuromuscular Advocacy Collaborative, its growing year-round presence, and what the group hopes to accomplish heading into the 2027 MDA Clinical and Scientific Conference.
The Editor-in-Chief of the Journal of the American Heart Association discussed what journal editors look for in stroke research submissions, how AI and open access are reshaping publishing, and the equity gaps that still exist for researchers in lower-income countries.
Mitzi Joi Williams, MD, is joined by Temitope Adeola, MD, and Chantale Branson, MD, to discuss migraine as a complex neurological condition, including recognizing symptoms and triggers, navigating acute and preventive treatment options, and incorporating lifestyle modifications to improve migraine management.
A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.
1.
More men with prostate cancer are avoiding unnecessary surgery
2.
High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?
3.
Young adults who are obese are at risk for 17 different types of cancer in the future.
4.
Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.
5.
Screening tests that are non-invasive show promise in detecting colorectal cancer.
1.
Degrader Platforms for Myeloid Cancers: Mechanisms, Clinical Implications, and Emerging Therapeutic Paradigms
2.
Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance
3.
Therapeutic Advances in Tumor Mechanotransduction Inhibition
4.
Hematopoietic Reserve Exhaustion in Chronic Blood Disorders
5.
Fatigue Management in Hematologic Disorders
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation